Amendment_1_RFP_NIAID_DAIDS_NIHAI2013170.pdf

AMENDMENT #1, RFP NIAID-DAIDS-NIHAI2013170 1

Amendment No. 1

NIAID-DAIDS-NIHAI2013170

“Preclinical Development Services for AIDS Therapeutics

Solicitation Number: NIAID-DAIDS-NIHAI2013170

Amendment Number:

One (1)

Amendment Issue Date:

July 1, 2013

Proposal Due Date: (Unchanged)

Friday, August 2, 2013 at 3:00 PM, Local Time

Issued By:

Michelle L. Scala

Contracting Officer

NIAID, NIH, DHHS

Office of Acquisitions, DEA

6700-B Rockledge Drive

Room 3106, MSC 7612

Bethesda, Maryland 20892-7612

Point of Contact: Craig Heggestad, Contract Specialist

E-mail: heggestadcd@niaid.nih.gov

OR

Michelle L. Scala, Contracting Officer

E-mail: ms35n@nih.gov

The purpose of Amendment 1 is to answer questions from potential offerors regarding the solicitation.

The date specified for receipt of proposals is unchanged.

Offerors must acknowledge receipt of this Amendment by identifying the amendment number and date of the amendment on each copy of the offer submitted. Failure to receive your acknowledgement may result in the rejection of your offer. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.

Question 1:

Attachment 1, page 3 of 4. Would the Government allow Offeror's to use a smaller font for tables and graphics?

Response to Question 1:

No. As stated in Attachment 1, all proposals must adhere to the 10 to 12 point font size requirement.

mailto:heggestadcd@niaid.nih.gov mailto:ms35n@nih.gov

AMENDMENT #1, RFP NIAID-DAIDS-NIHAI2013170 2

Question 2:

Attachment 4, page 1 section 1. It is our understanding, based on Attachment 4, page 1, section 1.

Project Management, that the costs for preparing responses to task order RFPs are chargeable to the program. Could the government confirm?

Response to Question 2:

Correct. Task Order proposal costs will be chargeable to the General Administrative and

Technical Support Task Order until the time Task Order issuance.

Question 3:

Attachment 8, page 1. The plasma half-life is stated at 5.2 days. Please confirm this is not intended to be 5.2 hours.

Response to Question 3:

The half-life is correct as written. As stated in Attachment 8 of the solicitation, “the plasma half-life of the compound was 5.2 days.”

End of Amendment #1 to RFP NIAID-DAIDS-NIHAI2013170